Biocon Limited has informed the Exchange about Schedule of meet

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.5%1-day move

₹356.60

prior close

₹358.05

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.7-0.2-0.2-0.3+1.5+1.5+1.8+0.6+1.8+7.1+19.7+20.5+18.5+21.6

Up moveDown movePending

AI summary

Biocon Limited has informed exchanges that its Board Meeting will be held on May 7, 2026 to consider and approve the audited standalone and consolidated financial results for Q4 and full year FY 2025-26 (ending March 31, 2026). The board will also discuss dividend recommendations. The company has scheduled an Earnings Conference Call with analysts and investors on May 8, 2026 at 9:00 AM IST. The trading window remains closed until May 9, 2026 as per insider trading regulations.

Likely market impact

This is a routine regulatory intimation with no immediate impact on the stock. Shareholders can expect Q4 and full year FY26 results to be announced around May 7, 2026, with analyst discussions on May 8.